Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 0.33 below Medicure Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Medicure Inc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 1875 to 3274.

Explain Quick Ratio?
How much Cash & cash equivalents MPH�s has?
What are MPH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MPH Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2024) Q4
Y / Y Current Liabilities Change	38.33 %	38.33 %	38.33 %	-	5.81 %
Y / Y Cash & cash equivalent Change	-46.67 %	-46.67 %	-46.67 %	-46.67 %	12.91 %
Quick Ratio MRQ	0.33	0.33	0.33	-	0.86
MPH's Total Ranking	# 3274	# 1875	#	#	#
Seq. Current Liabilities Change	0 %	0 %	-	-	0 %
Seq. Cash & cash equivalent Change	0 %	0 %	0 %	-46.67 %	0 %

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 443
Healthcare Sector	# 855
Overall Market	# 3274

Quick Ratio Statistics
High	Average	Low
1.43	0.71	0.22
(Dec 31 2018)		(Dec 31 2020)

Financial Statements
Medicure Inc 's Current Liabilities	$ 9 Millions	Visit MPH's Balance sheet
Medicure Inc 's Cash & cash equivalent	$ 3 Millions	Visit MPH's Balance sheet
Source of MPH's Sales		Visit MPH's Sales by Geography

Cumulative Medicure Inc 's Quick Ratio

MPH's Quick Ratio for the trailling 12 Months

MPH Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	3.75 %	-4.52 %	-13.03 %	-21.78 %	5.81 %
Y / Y Cash & cash equivalent TTM Growth	-46.67 %	-33.09 %	-18.69 %	-3.38 %	12.91 %
Quick Ratio TTM	0.44	0.59	0.78	1.01	0.86
Total Ranking TTM	# 3816	# 3693	#	#	#
Seq. Current Liabilities TTM Growth	10.18 %	11.33 %	12.78 %	-25 %	1.39 %
Seq. Cash & cash equivalent TTM Growth	-17.95 %	-15.22 %	-13.21 %	-11.67 %	2.94 %

Quick ratio ranking by company, industry and sector >> Back to MPH Financial Strength Comparisons >> Go to Compare MPH Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2025 to $8.90 millions, cumulative Quick Ratio decreased to 0.44 below the Medicure Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 438 other companies have achieved higher Quick Ratio than Medicure Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3693 to 3816.

Explain Quick Ratio?
How much Cash & cash equivalents MPH�s has?
What are MPH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 439
Healthcare Sector	# 900
Within the Market	# 3816

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.43	0.7	0.22
(Dec 31 2018)		(Dec 31 2020)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Ironwood Pharmaceuticals inc	0.89	$ 215.456 Millions	$ 243.145 Millions
Medicus Pharma Ltd	0.88	$ 8.705 Millions	$ 9.938 Millions
Serina Therapeutics Inc	0.86	$ 3.056 Millions	$ 3.563 Millions
Nls Pharmaceutics Ltd	0.86	$ 4.402 Millions	$ 5.139 Millions
Cormedix Inc	0.85	$ 157.330 Millions	$ 184.012 Millions
Oncolytics Biotech Inc	0.85	$ 5.202 Millions	$ 6.101 Millions
Axsome Therapeutics Inc	0.85	$ 322.933 Millions	$ 378.836 Millions
Integrated Biopharma Inc	0.85	$ 3.615 Millions	$ 4.248 Millions
Turn Therapeutics Inc	0.85	$ 5.085 Millions	$ 6.003 Millions
Harrow Inc	0.76	$ 72.927 Millions	$ 96.302 Millions
Lifevantage Corp	0.74	$ 20.201 Millions	$ 27.217 Millions
Supernus Pharmaceuticals inc	0.73	$ 128.448 Millions	$ 177.074 Millions
Evolus Inc	0.71	$ 53.826 Millions	$ 75.305 Millions
Geron Corporation	0.71	$ 79.440 Millions	$ 111.542 Millions
Karyopharm Therapeutics Inc	0.69	$ 63.744 Millions	$ 92.060 Millions
Eton Pharmaceuticals Inc	0.67	$ 25.942 Millions	$ 38.490 Millions
Pharming Group N v	0.66	$ 145.305 Millions	$ 221.690 Millions
Rein Therapeutics Inc	0.65	$ 3.215 Millions	$ 4.916 Millions
Journey Medical Corp	0.64	$ 24.090 Millions	$ 37.442 Millions
Ionis Pharmaceuticals Inc	0.64	$ 372.260 Millions	$ 579.151 Millions
Pfizer Inc	0.63	$ 23,454.000 Millions	$ 36,984.000 Millions
Lakewood-Amedex Biotherapeutics Inc.	0.62	$ 0.236 Millions	$ 0.381 Millions
Jazz Pharmaceuticals Plc	0.62	$ 1,391.899 Millions	$ 2,246.721 Millions
Ernexa Therapeutics Inc	0.61	$ 1.884 Millions	$ 3.113 Millions
Enlivex Therapeutics Ltd	0.60	$ 5.441 Millions	$ 9.021 Millions
Aurinia Pharmaceuticals Inc	0.59	$ 80.160 Millions	$ 135.252 Millions
Promis Neurosciences inc	0.59	$ 6.150 Millions	$ 10.441 Millions
Xencor Inc	0.58	$ 55.659 Millions	$ 95.907 Millions
Ascendis Pharma A	0.58	$ 691.961 Millions	$ 1,197.718 Millions
Earth Science Tech Inc	0.58	$ 1.811 Millions	$ 3.146 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.